DCAL Dishman Carbogen Amcis Ltd
Healthcare
LTP
145.15
CHG · %
-3.9 (-2.62%)
VOL · TODAY
84.11K
PREV CLOSE
149.05
Today's range144.6 · 149.9
145.15
52-week range128.5 · 303
145.15
Loading candles…
Dishman Carbogen Amcis Ltd operates in the pharmaceutical and specialty chemicals industries, providing contract research and manufacturing services as well as specialized pharmaceutical development and manufacturing. The company's business segments include Contract Research and Manufacturing Services (CRAMS) and Contract Development and Manufacturing Organization (CDMO). Its offerings encompass specialty chemicals, vitamins and chemicals, disinfectants, early-phase process research and development, late-stage clinical and commercial manufacturing, High Potent Active Pharmaceutical Ingredients (HiPo APIs), and Vitamin D analogues. With over 40 years of experience, Dishman Carbogen Amcis specializes in complex and challenging substances and maintains high-capacity manufacturing and research facilities. The company has a presence across multiple continents, including Switzerland, the UK, Europe, China, and other countries. No information on founders, key management, incorporation details, subsidiaries, or stock listings is provided.
DCAL is not part of any active scan today.
This page is a live market overview for Dishman Carbogen Amcis Limited (DCAL) on the BSE. As a listed security, Dishman Carbogen Amcis Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DCAL before placing trades on tick2trade.
As of the latest feed, DCAL last traded at ₹145.15 on BSE, down ₹3.9 (2.62%) from the previous close of ₹149.05. Today's session range is ₹144.6 – ₹149.9, against a 52-week band of ₹128.5 – ₹303. Traded volume today stands at 84.11K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for DCAL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DCAL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Dishman Carbogen Amcis Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DCAL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DCAL option chain page linked from this overview.
// similar in healthcare326 total